PL203912A1 - Sposob wytwarzania 4-dwufenylometylo-1-hydroksybenzylo-piperydyn - Google Patents

Sposob wytwarzania 4-dwufenylometylo-1-hydroksybenzylo-piperydyn

Info

Publication number
PL203912A1
PL203912A1 PL20391278A PL20391278A PL203912A1 PL 203912 A1 PL203912 A1 PL 203912A1 PL 20391278 A PL20391278 A PL 20391278A PL 20391278 A PL20391278 A PL 20391278A PL 203912 A1 PL203912 A1 PL 203912A1
Authority
PL
Poland
Prior art keywords
hydroxybenzyl
piperidine
making
diphenyl methyl
diphenyl
Prior art date
Application number
PL20391278A
Other languages
English (en)
Polish (pl)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of PL203912A1 publication Critical patent/PL203912A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
PL20391278A 1977-01-11 1978-01-10 Sposob wytwarzania 4-dwufenylometylo-1-hydroksybenzylo-piperydyn PL203912A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB931/77A GB1542823A (en) 1977-01-11 1977-01-11 Piperidine derivatives

Publications (1)

Publication Number Publication Date
PL203912A1 true PL203912A1 (pl) 1979-06-04

Family

ID=9713045

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20391278A PL203912A1 (pl) 1977-01-11 1978-01-10 Sposob wytwarzania 4-dwufenylometylo-1-hydroksybenzylo-piperydyn

Country Status (22)

Country Link
JP (1) JPS5387367A (xx)
BE (1) BE862769A (xx)
BG (1) BG28574A3 (xx)
CA (1) CA1101426A (xx)
CS (1) CS195652B2 (xx)
DD (1) DD134089A5 (xx)
DE (1) DE2800919A1 (xx)
DK (1) DK5778A (xx)
ES (1) ES465861A1 (xx)
FI (1) FI780028A (xx)
FR (1) FR2376846A1 (xx)
GB (1) GB1542823A (xx)
IL (1) IL53766A0 (xx)
IT (1) IT1103117B (xx)
LU (1) LU78839A1 (xx)
NL (1) NL7800146A (xx)
NO (1) NO780040L (xx)
PL (1) PL203912A1 (xx)
PT (1) PT67511B (xx)
SE (1) SE7800184L (xx)
SU (2) SU772482A3 (xx)
ZA (1) ZA78158B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650874A (en) * 1984-11-26 1987-03-17 G. D. Searle & Co. N-(aralkoxybenzyl)-4(benzhydryl) piperidines
US4628095A (en) * 1985-06-05 1986-12-09 G. D. Searle & Co. Substituted N-benzyl-4-(benzhydryl) piperidines
EP0228893A3 (en) * 1985-12-20 1990-01-03 A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment
GB9000305D0 (en) * 1990-01-06 1990-03-07 Pfizer Ltd Anticholinergic agents
WO1997022583A1 (de) * 1995-12-20 1997-06-26 Eckhart Pein Neue 1-phenylalkyl/alkylen-4-(.alpha.-hydroxydiphenylmethyl)-piperidin derivate und ihre verwendung als serotonin antagonisten
DE69924467T2 (de) * 1998-01-16 2006-02-16 Eisai Co., Ltd. Verfahren zur herstellung von donepezilderivaten
KR20050085673A (ko) * 2002-12-18 2005-08-29 에프엠씨 코포레이션 N-(치환된 아릴메틸)-4-(이치환된 메틸)피페리딘 및피페라진
WO2004103972A1 (ja) * 2003-05-20 2004-12-02 Ajinomoto Co.,Inc. 新規ピペリジン誘導体

Also Published As

Publication number Publication date
NO780040L (no) 1978-07-12
SE7800184L (sv) 1978-07-12
IT7847573A0 (it) 1978-01-10
IL53766A0 (en) 1978-04-30
CS195652B2 (en) 1980-02-29
PT67511A (fr) 1978-02-01
LU78839A1 (fr) 1978-09-18
ZA78158B (en) 1978-10-25
NL7800146A (nl) 1978-07-13
CA1101426A (en) 1981-05-19
PT67511B (fr) 1979-06-11
SU990761A1 (ru) 1983-01-23
BE862769A (fr) 1978-07-10
DD134089A5 (de) 1979-02-07
JPS5387367A (en) 1978-08-01
BG28574A3 (en) 1980-05-15
JPS6125031B2 (xx) 1986-06-13
FI780028A (fi) 1978-07-12
ES465861A1 (es) 1978-09-16
DE2800919A1 (de) 1978-07-13
DK5778A (da) 1978-07-12
IT1103117B (it) 1985-10-14
GB1542823A (en) 1979-03-28
SU772482A3 (ru) 1980-10-15
FR2376846A1 (fr) 1978-08-04
FR2376846B1 (xx) 1983-02-04

Similar Documents

Publication Publication Date Title
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
FI780034A (fi) Foerfarande foer framstaellning av metatrifluoro-metylfenylpiperazin
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL207835A1 (pl) Sposob etylowania monoalkilobenzenu
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL203912A1 (pl) Sposob wytwarzania 4-dwufenylometylo-1-hydroksybenzylo-piperydyn
PL211409A1 (pl) Sposob wytwarzania nowych podstawionych pirolidyn
PL208543A1 (pl) Sposob wytwarzania nowych imidazoizochinolinodionow
PL207592A1 (pl) Sposob wytwarzania nowych pirydazynylohydrazonow
PL209329A1 (pl) Sposob wytwarzania 2-chlorosulfinyloazetydynonow-4
PL210932A1 (pl) Sposob wytwarzania tiolokarbaminianow
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL204964A1 (pl) Sposob wytwarzania akantomycyny
PL211668A1 (pl) Sposob wytwarzania nowych 3-dwu-n-propyloacetoksybenzodiazepinonow-2
PL204882A1 (pl) Sposob wytwarzania nowych triazolo-tieno-dwuazepinonow-1
PL196842A1 (pl) Sposob wytwarzania nowych zasadowych barwnikow metinowych
DK4978A (da) Forgaeringsmetode
PL201824A1 (pl) Sposob wytwarzania m-benzoiloacetofenonu
PL204509A1 (pl) Sposob wytwarzania nowych dwuwodorobenzopiranoksantenonow
PL192043A1 (pl) Sposob wytwarzania polinitrozwiazkow
PL195376A1 (pl) Sposob wytwarzania 3-dezacetoksycefalosporyn
PL203230A1 (pl) Sposob wytwarzania tworzyw steatytowych
PL202536A1 (pl) Sposob wytwarzania tionitryli
PL201903A1 (pl) Sposob wytwarzania m-benzyloiloacetofenonu